Published in Biochem Biophys Res Commun on September 15, 1983
Glucose metabolism as a target of histone deacetylase inhibitors. Mol Endocrinol (2008) 1.01
Complete beta-oxidation of valproate: cleavage of 3-oxovalproyl-CoA by a mitochondrial 3-oxoacyl-CoA thiolase. Biochem J (2002) 0.92
Acetate represents a major product of heptanoate and octanoate beta-oxidation in hepatocytes isolated from neonatal piglets. Biochem J (1996) 0.81
Combined effects of a high-fat diet and chronic valproic acid treatment on hepatic steatosis and hepatotoxicity in rats. Acta Pharmacol Sin (2014) 0.81
Short-chain carboxylic acids, a new class of teratogens: studies of potential biochemical mechanisms. Environ Health Perspect (1986) 0.76
Valproate-induced Fanconi syndrome in a 27-year-old woman. J Gen Intern Med (2011) 0.75
Hirschsprung disease, associated syndromes and genetics: a review. J Med Genet (2007) 4.13
Mutations in the gene encoding fibroblast growth factor receptor-3 in achondroplasia. Nature (1994) 4.04
Mutations of the RET proto-oncogene in Hirschsprung's disease. Nature (1994) 3.33
A beta-galactosidase hybrid protein targeted to nuclei as a marker for developmental studies. Proc Natl Acad Sci U S A (1987) 3.23
Standardized MRD quantification in European ALL trials: proceedings of the Second International Symposium on MRD assessment in Kiel, Germany, 18-20 September 2008. Leukemia (2009) 2.30
Homozygous mutations in LPIN2 are responsible for the syndrome of chronic recurrent multifocal osteomyelitis and congenital dyserythropoietic anaemia (Majeed syndrome). J Med Genet (2005) 2.24
Mutation of the endothelin-3 gene in the Waardenburg-Hirschsprung disease (Shah-Waardenburg syndrome). Nat Genet (1996) 2.01
Differential effects of inactivated Axin1 and activated beta-catenin mutations in human hepatocellular carcinomas. Oncogene (2006) 1.84
Phenotypic spectrum of CHARGE syndrome in fetuses with CHD7 truncating mutations correlates with expression during human development. J Med Genet (2005) 1.80
A gene for Hirschsprung disease maps to the proximal long arm of chromosome 10. Nat Genet (1993) 1.79
A human model for multigenic inheritance: phenotypic expression in Hirschsprung disease requires both the RET gene and a new 9q31 locus. Proc Natl Acad Sci U S A (2000) 1.76
Targeted expression of a dominant-negative EGF-R in the kidney reduces tubulo-interstitial lesions after renal injury. J Clin Invest (2000) 1.68
Diversity of RET proto-oncogene mutations in familial and sporadic Hirschsprung disease. Hum Mol Genet (1995) 1.68
Spi-1/PU.1 transgenic mice develop multistep erythroleukemias. Mol Cell Biol (1996) 1.63
Haematopoietic stem cell transplantation for sickle cell anaemia: the first 50 patients transplanted in Belgium. Bone Marrow Transplant (1998) 1.57
Methemoglobinemia and hemolytic anemia after rasburicase administration in a child with leukemia. Int J Clin Pharm (2011) 1.55
Germline mutations of the RET ligand GDNF are not sufficient to cause Hirschsprung disease. Nat Genet (1996) 1.49
Mutation of the endothelin-receptor B gene in Waardenburg-Hirschsprung disease. Hum Mol Genet (1995) 1.45
A comparison of iodine-123 meta-iodobenzylguanidine scintigraphy and single bone marrow aspiration biopsy in the diagnosis and follow-up of 26 children with neuroblastoma. Eur J Nucl Med (1993) 1.44
A gene for achondroplasia-hypochondroplasia maps to chromosome 4p. Nat Genet (1994) 1.34
Neurological phenotype in Waardenburg syndrome type 4 correlates with novel SOX10 truncating mutations and expression in developing brain. Am J Hum Genet (2000) 1.26
Long-term results of three randomized trials (58831, 58832, 58881) in childhood acute lymphoblastic leukemia: a CLCG-EORTC report. Children Leukemia Cooperative Group. Leukemia (2000) 1.25
Overexpression of regenerating islet-derived 1 alpha and 3 alpha genes in human primary liver tumors with beta-catenin mutations. Oncogene (2006) 1.24
Spectrum of HLXB9 gene mutations in Currarino syndrome and genotype-phenotype correlation. Hum Mutat (2008) 1.21
Mutation of the RET ligand, neurturin, supports multigenic inheritance in Hirschsprung disease. Hum Mol Genet (1998) 1.19
Heterozygous endothelin receptor B (EDNRB) mutations in isolated Hirschsprung disease. Hum Mol Genet (1996) 1.19
Constitutional translocation t(1;17)(p36;q12-21) in a patient with neuroblastoma. Genes Chromosomes Cancer (1990) 1.19
Epistatic interactions with a common hypomorphic RET allele in syndromic Hirschsprung disease. Hum Mutat (2007) 1.19
A new recurrent inversion, inv(7)(p15q34), leads to transcriptional activation of HOXA10 and HOXA11 in a subset of T-cell acute lymphoblastic leukemias. Leukemia (2005) 1.18
Transgenic mice for MTCP1 develop T-cell prolymphocytic leukemia. Blood (1998) 1.18
Intracranial germ cell tumors: a comprehensive update of the European data. Neuropediatrics (1994) 1.14
Oxidation of fatty acids in cultured fibroblasts: a model system for the detection and study of defects in oxidation. Pediatr Res (1982) 1.12
Large-scale deletions and SMADIP1 truncating mutations in syndromic Hirschsprung disease with involvement of midline structures. Am J Hum Genet (2001) 1.11
Cholestasis is a marker for hepatocellular carcinomas displaying beta-catenin mutations. J Pathol (2007) 1.07
Hepatitis B virus X gene product acts as a transactivator in vivo. J Hepatol (1994) 1.03
Hepatic and muscular presentations of carnitine palmitoyl transferase deficiency: two distinct entities. Pediatr Res (1988) 1.03
Patterns of expression of position-dependent integrated transgenes in mouse embryo. Proc Natl Acad Sci U S A (1990) 1.01
Phenotype-genotype correlations in X linked retinitis pigmentosa. J Med Genet (1992) 1.00
Endothelin-3 gene mutations in isolated and syndromic Hirschsprung disease. Eur J Hum Genet (1998) 1.00
Inhibition of ureagenesis by valproate in rat hepatocytes. Role of N-acetylglutamate and acetyl-CoA. Biochem J (1983) 0.99
Time-course development of differentiated hepatocarcinoma and lung metastasis in transgenic mice. J Hepatol (1991) 0.99
In vivo activity of the hepatitis B virus core promoter: tissue specificity and temporal regulation. J Virol (1995) 0.97
Cytogenetic analysis of a mesenchymal hamartoma of the liver. Cancer Genet Cytogenet (1989) 0.97
Mutations of the fibroblast growth factor receptor-3 gene in achondroplasia. Horm Res (1996) 0.95
Correlation between blood ammonia concentration and organic acid accumulation in isovaleric and propionic acidemia. Pediatrics (1982) 0.94
Antenatal diagnosis of glutaricaciduria type II. Lancet (1983) 0.94
Assessing the role of alkane hydroxylase genotypes in environmental samples by competitive PCR. J Appl Microbiol (2005) 0.93
X-linked hydrocephalus: clinical heterogeneity at a single gene locus. Eur J Pediatr (1992) 0.93
Long segment and short segment familial Hirschsprung's disease: variable clinical expression at the RET locus. J Med Genet (1994) 0.92
A gene for Holt-Oram syndrome maps to the distal long arm of chromosome 12. Nat Genet (1994) 0.92
Diet-dependent carcinogenesis of pancreatic islets and liver in transgenic mice expressing oncogenes under the control of the L-type pyruvate kinase gene promoter. Oncogene (1992) 0.91
Chromosomal aberrations in Bloom syndrome patients with myeloid malignancies. Cancer Genet Cytogenet (2001) 0.90
Improved survival for acute lymphoblastic leukaemia in infancy: the experience of EORTC-Childhood Leukaemia Cooperative Group. Br J Haematol (1994) 0.89
Clinical, cytogenetic and molecular characteristics of 14 T-ALL patients carrying the TCRbeta-HOXA rearrangement: a study of the Groupe Francophone de Cytogénétique Hématologique. Leukemia (2006) 0.89
Fatal hyperammonemia resulting from a C-to-T mutation at a MspI site of the ornithine transcarbamylase gene. Hum Genet (1991) 0.89
Mutations of the RET-GDNF signaling pathway in Ondine's curse. Am J Hum Genet (1998) 0.89
The gene for X-linked hydrocephalus maps to Xq28, distal to DXS52. Genomics (1992) 0.88
A case of retinoblastoma, associated with histiocytosis-X and mosaicism of a deleted D-group chromosome (13q14 leads to q31). Clin Genet (1982) 0.88
Symptomatic pineal cysts: clinical manifestations and management. Acta Neurochir (Wien) (2002) 0.87
Detection of subtle reciprocal translocations by fluorescence in situ hybridization. Clin Genet (1992) 0.87
Pulmonary and mediastinal lesions in children with Langerhans cell histiocytosis. Pediatr Radiol (1997) 0.87
A mechanism for valproate-induced hyperammonemia. Adv Exp Med Biol (1982) 0.87
The Eighth International Childhood Acute Lymphoblastic Leukemia Workshop ('Ponte di legno meeting') report: Vienna, Austria, April 27-28, 2005. Leukemia (2006) 0.86
Mutations of the RET gene in isolated and syndromic Hirschsprung's disease in human disclose major and modifier alleles at a single locus. J Med Genet (2006) 0.86
Protective effects of SR 57746A in central and peripheral models of neurodegenerative disorders in rodents and primates. Neuroscience (1993) 0.86
Surveillance of cytomegalovirus (CMV) DNAemia in pediatric allogeneic stem cell transplantation: incidence and outcome of CMV infection and disease. Transpl Infect Dis (2007) 0.86
Transcriptional selectivity in early mouse embryos: a qualitative study. Nucleic Acids Res (1991) 0.85
The calcium-sensing receptor as a regulator of cellular fate in normal and pathological conditions. Curr Mol Med (2013) 0.85
Investigation of germline GFR alpha-1 mutations in Hirschsprung disease. J Med Genet (1999) 0.85
Sensitive and reliable detection of genomic imbalances in human neuroblastomas using comparative genomic hybridisation analysis. Eur J Cancer (1997) 0.85
In vivo activation by ultraviolet rays of the human immunodeficiency virus type 1 long terminal repeat. J Clin Invest (1990) 0.85
Neuronal-specific expression of human copper-zinc superoxide dismutase gene in transgenic mice: animal model of gene dosage effects in Down's syndrome. Brain Res (1991) 0.85
Hudson memorial lecture. Neonatal management of organic acidurias. Clinical update. J Inherit Metab Dis (1984) 0.85
Homozygosity for a frequent and weakly penetrant predisposing allele at the RET locus in sporadic Hirschsprung disease. J Med Genet (2005) 0.84
Technetium-99m sestamibi imaging in paediatric neuroblastoma and ganglioneuroma and its relation to P-glycoprotein. Eur J Nucl Med (1999) 0.84
Contribution to carrier detection and genetic counselling in X linked retinoschisis. J Med Genet (1991) 0.83
A mechanism for valproate-induced hyperammonemia. Pediatr Res (1981) 0.83
Developmental changes of citrullinogenesis, mitochondrial N-acetylglutamate content and N-acetylglutamate synthetase in fetal and neonatal rats. Biochimie (1983) 0.83
Correction of mouse ornithine transcarbamylase deficiency by gene transfer into the germ line. Nucleic Acids Res (1988) 0.83
Gender difference in aerobic capacity in adolescents after cure from malignant disease in childhood. Acta Paediatr (1993) 0.83
Oral BVDU treatment of varicella and zoster in children with cancer. Eur J Pediatr (1985) 0.82
De-novo mutations of the RET proto-oncogene in Hirschsprung's disease. Lancet (1995) 0.82
Dobutamine stress echocardiography in the evaluation of late anthracycline cardiotoxicity in childhood cancer survivors. Pediatr Res (1996) 0.82
A probable sex difference in mutation rates in ornithine transcarbamylase deficiency. Hum Genet (1990) 0.82
P-glycoprotein is an independent prognostic factor predicting relapse in childhood acute lymphoblastic leukaemia: results of a 6-year prospective study. Br J Haematol (1999) 0.81
Linkage disequilibrium in inbred North African families allows fine genetic and physical mapping of triple A syndrome. Eur J Hum Genet (2000) 0.81
The amino-terminal region of SV40 large T antigen is sufficient to induce hepatic tumours in mice. Oncogene (1998) 0.80
A 7 bp deletion of the RET proto-oncogene in familial Hirschsprung's disease. Hum Mol Genet (1994) 0.80
A novel polymorphism in the coding sequence of the human RET proto-oncogene. Hum Genet (1994) 0.80
GDNF as a candidate modifier in a type 1 neurofibromatosis (NF1) enteric phenotype. J Med Genet (2001) 0.80
Expression of the RET proto-oncogene in human embryos. Am J Med Genet (1998) 0.80
Treatment outcome in infant acute lymphoblastic leukemia. Children Leukemia Cooperative Group--EORTC. European Organization for Research and Treatment of Cancer. Blood (2000) 0.80
Compensatory apoptosis in response to SV40 large T antigen expression in the liver. Oncogene (1995) 0.80
Pentasomy 21 characterizing spontaneously regressing congenital acute leukemia. Cancer Genet Cytogenet (1983) 0.80
[Mutations of RET proto-oncogene in Hirschsprung disease]. C R Acad Sci III (1994) 0.79
Tandem duplication within the neurofibromatosis type 1 gene (NF1) and reciprocal t(15;16)(q26.3;q12.1) translocation in familial association of NF1 with intestinal neuronal dysplasia type B (IND B) J Med Genet (2000) 0.79